⏰ Last few days for a highly motivated Research #ProgrammeManager to join our #CellularGenomics programme at Earlham Institute.
Applications close 14 December!
buff.ly/gi0hGKI
@whaerty.bsky.social
Latest posts tagged with #CellularGenomics on Bluesky
⏰ Last few days for a highly motivated Research #ProgrammeManager to join our #CellularGenomics programme at Earlham Institute.
Applications close 14 December!
buff.ly/gi0hGKI
@whaerty.bsky.social
We're looking for a Programme Manager to lead the coordination and delivery of our #CellularGenomics programme at Earlham Institute.
This role is open to part-time/flexible working and applications close 14 December 👇
We're recruiting a highly motivated Research Programme Manager to join our #CellularGenomics programme at Earlham Institute.
This is diverse role offers an excellent opportunity for someone looking to transition into #projectmanagement within a cutting-edge research environment.
A novel paradigm for single-cell annotation in stem cell research. Explores different approaches, implementation challenge in stem cell-derived models, and offers recommendations and a vision for the future. #hPSC #singlecell #cellulargenomics #AI #cellannotation https://ow.ly/jwl050Xo5Fq
ISSCR
Great to see Group Leader Dr Wilfried Haerty (@whaerty.bsky.social) presenting his work at #PacBioPRISM this afternoon!
Dr Haerty leads our #CellularGenomics research programme and is interested in the impact of variation on gene and transcript expression across scale.
@pacbio.bsky.social
ℹ️ Our #CellularGenomics programme brings together multi-disciplinary expertise from across the Earlham Institute alongside our core partners, to study somatic variation at cellular level and its role in environmental adaptation. 🧬
#BritishScienceWeek 🧪
As part of the Earlham Institute’s #CellularGenomics research programme, scientists at the Earlham Institute are combining #singlecell methods with long-read #sequencing to investigate the role of alternative splicing events on cell differentiation in both health and disease fields.